Multiple myeloma diagnosed in a patient from a blood center in northeastern Brazil: a case study

Abstract

Objective: Discuss the findings obtained through laboratory analysis, as well as the drugs administered and monitoring of a patient who has MM, treated at a blood center in northeastern Brazil. Case details: male, 77 years old, of Caucasian ethnicity, married, born in a city in northeastern Brazil, sought the Unified Health Service (SUS), presenting a condition of tingling and excessive numbness in the extremities of the fingers due to several symptoms. Immediately after performing laboratory tests, it was confirmed by immunophenotyping by flow cytometry, from the bone marrow aspirate, that it was a medullary hematological neoplasm and revealed the presence of 12.6% of plasma cells, clonal for the kappa chain. (k) light; multiple myeloma type. The patient started using the combined drug thalidomide-dexamethasone and has been obtaining advantageous results during the course of the therapy. From the newly diagnosed to the present day, he has been reacting beneficially to the treatment. Final considerations: Thus, there is a long way to go in order to improve the therapy, however we hope that the unfolding of this work can help in the survival of patients with Multiple Myeloma.